2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Multiple Myeloma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Carcinoma, Non-Small-Cell Lung
6
Neoplasm, Residual
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Colorectal Neoplasms
2
Uterine Cervical Neoplasms
1
Smoldering Multiple Myeloma
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Plasma Cell
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Plasma Cell
1
Interventions
Cisplatin
55
Carboplatin
49
pembrolizumab
42
Paclitaxel
42
Gemcitabine
28
Pemetrexed
23
Radiotherapy
21
Magnetic Resonance Spectroscopy
20
Radiotherapy, Intensity-Modulated
18
Cetuximab
18
Docetaxel
17
Specimen Handling
16
Nivolumab
16
Fluorouracil
16
Cyclophosphamide
14
durvalumab
13
Bevacizumab
13
Sorafenib
12
Radiation
11
Sunitinib
10
Platinum
10
130-nm albumin-bound paclitaxel
10
1,2-diaminocyclohexaneplatinum II citrate
10
osimertinib
9
Oxaliplatin
8
Irinotecan
8
Ipilimumab
8
Everolimus
8
Drug Therapy
8
Capecitabine
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma
×
Maintenance
×
Clear all
NCT06827353
2025-02-14
OVNI-B
Centre Hospitalier Universitaire de NÄ«mes
Recruiting
300 enrolled